Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026
Company to host webcast tomorrow at 8:00 a.m. EDT NEW YORK–(BUSINESS WIRE)–Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage... Read more.
RBLX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Roblox Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–$RBLX #RBLX–The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Roblox Corporation... Read more.
Syntax Bio Announces Expanded Series A and Leadership Appointments
Company raises additional capital to advance Cellgorithm™ platform, develop pancreatic beta cell therapy for type 1 diabetes and strengthen leadership CHICAGO–(BUSINESS... Read more.
INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
SAN DIEGO–(BUSINESS WIRE)–$ADMA #ADMA–The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of ADMA Biologics,... Read more.
INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
SAN DIEGO–(BUSINESS WIRE)–$ADMA #ADMA–The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of ADMA Biologics,... Read more.
iSOFT Contributes Intelligent Driving OS as AUTOSAR CAPI Global Code Baseline
SHANGHAI–(BUSINESS WIRE)–At the 17th AUTOSAR Open Conference (AOC) in Shanghai, iSOFT (iSOFT Infrastructure Software Co., Ltd.) contributed its self-developed... Read more.
CORRECTING and REPLACING Two Prime Earns SOC 1 Type 2 and SOC 2 Type 2 Designation
Independent third-party examinations validate operating effectiveness of firm’s financial reporting, security, and confidentiality controls. Examinations revealed... Read more.
NVCR Investors Have Opportunity to Join NovoCure Limited Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$NVCR—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims... Read more.
ACN Investors Have Opportunity to Join Accenture plc Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$ACN—The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims... Read more.
BRCB Investors Have Opportunity to Lead Black Rock Coffee Bar, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–$BRCB—The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit... Read more.